[Skip to Navigation]
Sign In
December 1996

Transforming Growth Factor-β1 Inhibits Synthesis of Cytokines in Endotoxin-Stimulated Human Whole Blood

Author Affiliations

From the Division of Trauma Surgery, University Hospital Zurich, Zurich, Switzerland (Dr Ertel and Ms Steckholzer); GSF-Forschungszentrum für Umwelt und Gesundheit, Institute of Experimental Hematology, Munich, Germany (Drs Karres and Kremer); and the Laboratoire de Biophysique, Faculté de Pharmacie, Université Louis Pasteur Strasbourg, Illkirch-Graffenstaden, France (Mr Kenney).

Arch Surg. 1996;131(12):1310-1317. doi:10.1001/archsurg.1996.01430240064008

Objective:  To determine the potency of transforming growth factor-β (TGF-β) for inhibiting proinflammatory cytokine synthesis in endotoxin-stimulated human whole blood.

Design:  Endotoxin-stimulated whole blood from healthy volunteers as an ex vivo model of endotoxemia was incubated with different concentrations of TGF-β1. Cytokine levels in plasma with a bioassay (for tumor necrosis factor α) or an enzyme-linked immunosorbent assay (for interleukin [IL]-1β and IL-6), messenger RNA (mRNA) expression with northern blotting, and protein levels with Western blotting were determined.

Results:  High TGF-β1 concentrations (>100 pg/mL) inhibited (P<.05) secretion of tumor necrosis factor α, IL-1β, and IL-6 into lipopolysaccharide-stimulated whole blood, while low concentrations (<50 pg/mL) were ineffective. Moreover, TGF-β1 inhibited mRNA expression of tumor necrosis factor α and IL-6 in a dose-dependent manner. In contrast, neither IL-1β mRNA expression nor IL-1β protein synthesis were attenuated by TGF-β1.

Conclusion:  Transforming growth factor-β1, with its downregulatory effect on the synthesis and release of proinflammatory cytokines by phagocytic cells, represents an inhibitor of endotoxin-induced inflammatory reactions.Arch Surg. 1996;131:1310-1317

Add or change institution